Advanced manufacturing technologies (AMTs) can speed drug development, improve quality and minimize drug shortages. Consequently, the FDA encourages early adoption of these technologies.
This webinar will explore how digital transformation enhances the efficiency, accuracy, and reliability of process analytical technology (PAT) and quality control systems. We will present the principles and applications of PAT highlighting the importance of real-time monitoring and high-fidelity control of production processes. Attendees will gain insights into the latest digital tools in quality assurance and process control, ensuring compliance with regulatory standards and improving overall product quality. They will learn how PAT and associated technologies improve knowledge transfer and propagate accessibility from R&D to full-scale production. Join us to discover how these advances are shaping the future of late development and advanced manufacturing and learn practical strategies for implementing these technologies in your operations.
Session 1: 11:00 a.m.
Enabling Digitalization from R&D to Manufacturing - AI Ready Data through Ingestion & Standardization
Session 2: 11:25 a.m.
How vibrational spectroscopy helps to accelerate new drug development and troubleshoot drug production
Session 3: 11:50 a.m.
The Benefits of Raman Spectroscopy for the Understanding and Control of Pharmaceutical Processes
Session 4: 12:15 p.m.
Advancing Continuous Process Monitoring and Optimization with Benchtop NMR in PAT
November 20, 2024 | 11:00 a.m. EST
SESSION 1
SESSION 4
Dr. Sergey Shilov
North America Product Manager, Science Business Unit, Bruker Optics
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciY
Mark Kemper
Associate Director, Business Development, Tornado Spectral Systems
Matteo Pennestri, Ph. D.
Team Leader, PAT and Automation, Pharma Business Unit Bruker BioSpin